The eLEGS exoskeleton grants the biggest wish a paralytic could ever make: the ability to walk again after being paralyzed from the waist down.
Developed by Berkeley Bionics, the eLEGS exoskeleton is currently being readied for clinical trials. According to New Scientist, it "is specifically designed as a rehabilitation device to help restore walking function to people with spinal cord injuries, as well as improving blood circulation and digestion," rather than for augmenting human strength like similar exoskeletons.
What's Driving This Trend
- Rehabilitation Exoskeletons
- The eLEGS exoskeleton is a new form of rehabilitation technology that enables paralytics to walk again.
- Medical Mobility Devices
- Therapeutic tech walkers like the eLEGS exoskeleton are enabling people with spinal cord injuries to regain mobility and improve their overall well-being.
- Assistive Robotics
- The development of exoskeletons such as the eLEGS highlights the potential for assistive robotics to transform the lives of individuals with mobility impairments.
Who This Affects Most
- Healthcare
- The eLEGS exoskeleton represents a disruptive innovation opportunity in the healthcare industry, particularly in the field of rehabilitation and mobility assistive devices.
- Medical Technology
- The emergence of therapeutic tech walkers like eLEGS creates opportunities for disruptive innovation in the medical technology industry, revolutionizing the way we approach physical rehabilitation.
- Mobility and Accessibility
- The development and advancement of therapeutic tech walkers like eLEGS presents disruptive innovation opportunities in the field of mobility and accessibility, enabling individuals with mobility impairments to regain independence and freedom of movement.
